Adult and paediatric patients with minimal change nephrotic syndrome show no major alterations in glomerular expression of sulphated heparan sulphate domains

Nephrology Dialysis Transplantation

Volumn 22, Issue 10, 2007, Pages 2886-2893

  Wijnhoven, Tessa J M ^a,b   Geelen, Joyce M ^b   Bakker, Marinka ^a   Lensen, Joost F M ^a   Rops, Angelique L W M M ^a   Kramer, Andrea B ^c   Navis, Gerjan ^c   Van Den Hoven, Mabel J W ^a   Van Der Vlag, Johan ^a   Berden, Jo H M ^a,b   Wetzels, Jack F M ^b   Van Den Heuvel, Lambert P W J ^b   Monnens, Leo A H ^b   Van Kuppevelt, Toin H ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Heparan sulphate; Immunofluorescence staining; Kidney; Minimal change nephrotic syndrome; Proteinuria, sulphation

Indexed keywords

HEPARAN SULFATE; PREDNISONE;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CHILD; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GLOMERULUS BASEMENT MEMBRANE; HUMAN; IMMUNOFLUORESCENCE; KIDNEY BIOPSY; KIDNEY DISEASE; MALE; NEPHROTIC SYNDROME; PEDIATRICS; PODOCYTE; PRIORITY JOURNAL;

ADULT; AGED; ANIMALS; BIOPSY; CHILD; CHILD, PRESCHOOL; DOXORUBICIN; FEMALE; GENE EXPRESSION REGULATION; HEPARITIN SULFATE; HUMANS; KIDNEY; KIDNEY GLOMERULUS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; NEPHROTIC SYNDROME; PODOCYTES; RATS; RATS, WISTAR;

EID: 36048988771     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm301     Document Type: Article

References (23)

1. Wernerson A, Duner F, Pettersson E et al. Altered ultrastructural distribution of nephrin in minimal change nephrotic syndrome. Nephrol Dial Transplant 2003; 18: 70-76
2. Patrakka J, Lahdenkari AT, Koskimies O, Holmberg C, Wartiovaara J, Jalanko H. The number of podocyte slit diaphragms is decreased in minimal change nephrotic syndrome. Pediatr Res 2002; 52: 349-355
3. Bridges CR, Myers BD, Brenner BM, Deen WM. Glomerular charge alterations in human minimal change nephropathy. Kidney Int 1982; 22: 677-684
4. Winetz JA, Robertson CR, Golbetz HV, Carrie BJ, Salyer WR, Myers BD. The nature of the glomerular injury in minimal change and focal sclerosing glomerulopathies. Am J Kidney Dis 1981; 1: 91-98
5. Kitano Y, Yoshikawa N, Nakamura H. Glomerular anionic sites in minimal change nephrotic syndrome and focal segmental glomerulosclerosis. Clin Nephrol 1993; 40: 199-204
6. Esko JD, Lindahl U. Molecular diversity of heparan sulfate. J Clin Invest 2001; 108: 169-173
7. van den Born J, van den Heuvel LP, Bakker MA et al. Distribution of GBM heparan sulfate proteoglycan core protein and side chains in human glomerular diseases. Kidney Int 1993; 43: 454-463
8. Holt RC, Webb NJ, Ralph S, Davies J, Short CD, Brenchley PE. Heparanase activity is dysregulated in children with steroid-sensitive nephrotic syndrome. Kidney Int 2005; 67: 122-129
9. Birmele B, Thibault G, Nivet H, de Agostini A, Girardin EP. In vitro decrease of glomerular heparan sulfate by lymphocytes from idiopathic nephrotic syndrome patients. Kidney Int 2001; 59: 913-922
10. van Kuppevelt TH, Dennissen MA, van Venrooij WJ, Hoet RM, Veerkamp JH. Generation and application of type-specific antiheparan sulfate antibodies using phage display technology. Further evidence for heparan sulfate heterogeneity in the kidney. J Biol Chem 1998; 273: 12960-12966
11. Jadresic LP, Filler G, Barratt TM. Urine glycosaminoglycans in congenital and acquired nephrotic syndrome. Kidney Int 1991; 40: 280-284
12. Wijnhoven TJ, Lensen JF, Wismans RG et al. In vivo degradation of heparan sulfate in the glomerular basement membrane does not result in proteinuria. J Am Soc Nephrol 2007; 18: 823-832
13. Harvey S, Burgess R, Miner JH. Podocyte-derived agrin is responsible for glomerular basement membrane anionic charge [Abstract]. J Am Soc Nephrol 2005; 16 Abstracts Issue: Nr. TH-FC003
14. Rossi M, Morita H, Sormunen R et al. Heparan sulfate chains of perlecan are indispensable in the lens capsule but not in the kidney. EMBO J 2003; 22: 236-245
15. Zcharia E, Metzger S, Chajek-Shaul T et al. Transgenic expression of mammalian heparanase uncovers physiological functions of heparan sulfate in tissue morphogenesis, vascularization, and feeding behavior. FASEB J 2004; 18: 252-263
16. Van den Heuvel LP, Van den Born J, Jalanko H et al. The glycosaminoglycan content of renal basement membranes in the congenital nephrotic syndrome of the Finnish type. Pediatr Nephrol 1992; 6: 10-15
17. Koop K, Eikmans M, Baelde HJ et al. Expression of podocyte-associated molecules in acquired human kidney diseases. J Am Soc Nephrol 2003; 14: 2063-2071
18. Srivastava T, Garola RE, Whiting JM, Alon US. Synaptopodin expression in idiopathic nephrotic syndrome of childhood. Kidney Int 2001; 59: 118-125
19. Regele HM, Fillipovic E, Langer B et al. Glomerular expression of dystroglycans is reduced in minimal change nephrosis but not in focal segmental glomerulosclerosis. J Am Soc Nephrol 2000; 11: 403-412
20. Charest PM, Roth J. Localization of sialic acid in kidney glomeruli: regionalization in the podocyte plasma membrane and loss in experimental nephrosis. Proc Natl Acad Sci U S A 1985; 82: 8508-8512
21. Kerjaschki D, Vernillo AT, Farquhar MG. Reduced sialylation of podocalyxin-the major sialoprotein of the rat kidney glomerulus-in aminonucleoside nephrosis. Am J Pathol 1985; 118: 343-349
22. Blau EB, Haas JE. Glomerular sialic acid and proteinuria in human renal disease. Lab Invest 1973; 28: 477-481
23. Singh A, Satchell SC, Neal CR, Mathieson PW. The human glomerular endothelial glycocalyx contributes to endothelial barrier function in vitro. J Am Soc Nephrol 2006; 17: Abstracts Issue:Nr. TH-PO787